(Last updated : 2024-01-28 16:26:28)
  Hiromichi Yamane
   Department   Kawasaki Medical School  Kawasaki Medical School, Department of General Internal Medicine 4,
   Position   Associate Professor
■ BooK
1. 2016/01   Present issues of cancer survivorship in Japan 
2. 2011/09   “Hairy morphology” of hairy cell leukemia-Japanese variant may disappear under specific conditions, BloodMed 
3. 2011/07   HHV8- unrelated primary effusion lymphoma- like lymphoma in an elderly man, BloodMed 
4. 2011/06   Asian intravascular B-cell lymphoma relapsing in both adrenal glands simultaneously., BloodMed 
■ Journal
1. 2011/05 Synchronous double primary lung cancers with different response to pemetrexed. 
2. 2011/07 CD5-positive diffuse large B-cell lymphoma: a retrospective study in 337 patients treated by chemotherapy with or without rituximab. 
3. 2011/07 An oral fluoropyrimidine agent S-1 induced interstitial lung disease: A case report. 
4. 2011/10 Spontaneous regression of pulmonary pure ground-glass opacity with progression of a solid component during a 40-month follow-up 
5. 2011/10 Interstitial lung disease associated with gemcitabine treatment in patients with non-small-cell lung cancer and pancreatic cancer. 
Display all(61)
■ Presentation
1. 2014/04/27 Circulating TARC/CCL17 is a possible diagnostic marker for interstitial lung disease (ILD) in patients with non-small cell lung cancer (NSCLC) (Poster notice,General) 
2. 2022/02/17 Long-term response to alectinib in a patient with ALK-fusion genemerged in afatinib-resistant EGFR mutated lung cancer (Poster notice,General) 
3. 2021/10/21 非高齢者進⾏肺癌に対する免疫チェックポイント阻害薬投与と帯状疱疹発症の検討 (Speech,General) 
4. 2018/07/20 Patients with osteosarcoma and soft tissue sarcoma tend to become cancer refugees in
Japanese regional cities (Poster notice) 
5. 2016/04/20 Synergistic effect of pacritinib with erlotinib on JAK2-mediated resistance in epidermal gowth factor receptor mutation-positive non-small cell lung Cancer (Poster notice) 
Display all(8)